EE03235B1 - Emulsioonvorm, selle valmistamise protsess ja kasutamine - Google Patents

Emulsioonvorm, selle valmistamise protsess ja kasutamine

Info

Publication number
EE03235B1
EE03235B1 EE9400426A EE9400426A EE03235B1 EE 03235 B1 EE03235 B1 EE 03235B1 EE 9400426 A EE9400426 A EE 9400426A EE 9400426 A EE9400426 A EE 9400426A EE 03235 B1 EE03235 B1 EE 03235B1
Authority
EE
Estonia
Prior art keywords
pct
preparation
formulation
sec
optionally
Prior art date
Application number
EE9400426A
Other languages
English (en)
Inventor
Lundquist Stefan
Original Assignee
Astra Aktiebolag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Aktiebolag filed Critical Astra Aktiebolag
Publication of EE03235B1 publication Critical patent/EE03235B1/et

Links

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Nanotechnology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Medical Informatics (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Medicinal Preparation (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Bakery Products And Manufacturing Methods Therefor (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cosmetics (AREA)
EE9400426A 1993-10-07 1994-11-23 Emulsioonvorm, selle valmistamise protsess ja kasutamine EE03235B1 (et)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9303281A SE9303281D0 (sv) 1993-10-07 1993-10-07 New formulation

Publications (1)

Publication Number Publication Date
EE03235B1 true EE03235B1 (et) 1999-12-15

Family

ID=20391342

Family Applications (1)

Application Number Title Priority Date Filing Date
EE9400426A EE03235B1 (et) 1993-10-07 1994-11-23 Emulsioonvorm, selle valmistamise protsess ja kasutamine

Country Status (31)

Country Link
US (2) US5843465A (et)
EP (1) EP0722316B1 (et)
JP (1) JPH09504279A (et)
CN (1) CN1134663A (et)
AT (1) ATE189119T1 (et)
AU (1) AU701512B2 (et)
BR (1) BR9407748A (et)
CA (1) CA2172143A1 (et)
CZ (1) CZ94396A3 (et)
DE (1) DE69422818T2 (et)
DK (1) DK0722316T3 (et)
EE (1) EE03235B1 (et)
EG (1) EG20540A (et)
ES (1) ES2145158T3 (et)
FI (1) FI961525A0 (et)
GR (1) GR3033255T3 (et)
HK (1) HK1009257A1 (et)
HU (1) HUT74638A (et)
IL (1) IL111131A (et)
IS (1) IS4209A (et)
MA (1) MA23344A1 (et)
NO (1) NO961363D0 (et)
NZ (1) NZ274583A (et)
PL (1) PL313767A1 (et)
PT (1) PT722316E (et)
SE (1) SE9303281D0 (et)
SG (1) SG47896A1 (et)
SK (1) SK39396A3 (et)
TN (1) TNSN94099A1 (et)
WO (1) WO1995009609A1 (et)
ZA (1) ZA947351B (et)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7799337B2 (en) 1997-07-21 2010-09-21 Levin Bruce H Method for directed intranasal administration of a composition
US6054421A (en) * 1997-09-23 2000-04-25 Scimed Life Systems, Inc. Medical emulsion lubricant
US6281175B1 (en) 1997-09-23 2001-08-28 Scimed Life Systems, Inc. Medical emulsion for lubrication and delivery of drugs
US20100184732A1 (en) * 2000-09-15 2010-07-22 Mcdonald George Method of long-term treatment of graft-versus-host disease using topical active corticosteroids
US20020086857A1 (en) * 2000-09-15 2002-07-04 Mcdonald George B. Method of long-term treatment of graft-versus-host disease using topical active corticosterioids
DE10059430A1 (de) * 2000-11-30 2002-06-06 Cognis Deutschland Gmbh Feinteilige Emulsionen
KR100915741B1 (ko) 2001-06-15 2009-09-04 코너스톤 파마슈티칼스 표적 조직 및 세포를 치료하기에 유용한 나노입자를함유하는 약제학적 및 진단학적 조성물
BR0211705A (pt) * 2001-08-06 2004-09-28 Astrazeneca Ab Processo para a preparação de uma dispersão estável de partìculas sólidas em um meio aquoso, dispersão estável aquosa, partìcula sólida, composição farmacêutica, método para a inibição do amadurecimento de ostwald em uma dispersão de partìculas sólidas substancialmente insolúveis em água em um meio aquoso, e, uso de um inibidor
TWI248159B (en) * 2002-01-25 2006-01-21 Nanya Technology Corp Manufacturing method for shallow trench isolation with high aspect ratio
GB0216700D0 (en) * 2002-07-18 2002-08-28 Astrazeneca Ab Process
US7544674B2 (en) 2002-10-25 2009-06-09 Galderma S.A. Topical skin care composition
US8685428B2 (en) * 2002-12-10 2014-04-01 Advanced Cardiovascular Systems, Inc. Therapeutic composition and a method of coating implantable medical devices
GB0230087D0 (en) * 2002-12-24 2003-01-29 Astrazeneca Ab Therapeutic agents
GB0230088D0 (en) * 2002-12-24 2003-01-29 Astrazeneca Ab Therapeutic agents
GB0302672D0 (en) * 2003-02-06 2003-03-12 Astrazeneca Ab Pharmaceutical formulations
GB0302673D0 (en) * 2003-02-06 2003-03-12 Astrazeneca Ab Pharmaceutical formulations
GB0302671D0 (en) * 2003-02-06 2003-03-12 Astrazeneca Ab Pharmaceutical formulations
US7323206B1 (en) 2003-03-04 2008-01-29 B. Braun Medical Inc. Reagents and methods for all-in-one total parenteral nutrition for neonates and infants
US20060135523A1 (en) * 2003-06-18 2006-06-22 Astrazeneca Ab 2-substituted 5,6-diaryl-pyrazine derivatives as cb1 modulator
GB0314057D0 (en) * 2003-06-18 2003-07-23 Astrazeneca Ab Therapeutic agents
GB0314261D0 (en) * 2003-06-19 2003-07-23 Astrazeneca Ab Therapeutic agents
EP1696868A1 (en) * 2003-07-18 2006-09-06 Hill Dermaceuticals, Inc. Topical skin care composition containing refined peanut oil
US20070140999A1 (en) * 2003-07-18 2007-06-21 Hill Dermaceuticals, Inc. Topical skin care composition containing refined peanut oil
US20060099173A1 (en) * 2003-10-24 2006-05-11 Nancy Puglia Topical skin care composition
US20070207107A1 (en) * 2006-03-03 2007-09-06 Gareth Winckle Silicone based emulsions for topical drug delivery
US8473062B2 (en) 2008-05-01 2013-06-25 Autonomic Technologies, Inc. Method and device for the treatment of headache
US8412336B2 (en) 2008-12-29 2013-04-02 Autonomic Technologies, Inc. Integrated delivery and visualization tool for a neuromodulation system
US9320908B2 (en) 2009-01-15 2016-04-26 Autonomic Technologies, Inc. Approval per use implanted neurostimulator
US8494641B2 (en) 2009-04-22 2013-07-23 Autonomic Technologies, Inc. Implantable neurostimulator with integral hermetic electronic enclosure, circuit substrate, monolithic feed-through, lead assembly and anchoring mechanism

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4073943A (en) * 1974-09-11 1978-02-14 Apoteksvarucentralen Vitrum Ab Method of enhancing the administration of pharmalogically active agents
AT358530B (de) * 1978-04-25 1980-09-10 Plc Pharma Licences Stabilisierungsverfahren
JPS58222014A (ja) * 1982-06-18 1983-12-23 Taisho Pharmaceut Co Ltd プロスタグランジンｅ↓１脂肪乳剤
US4622219A (en) * 1983-06-17 1986-11-11 Haynes Duncan H Method of inducing local anesthesia using microdroplets of a general anesthetic
JPH0818989B2 (ja) * 1984-01-12 1996-02-28 株式会社ミドリ十字 脂肪乳剤中のプロスタグランジンの安定化方法
JPH0647533B2 (ja) * 1984-08-10 1994-06-22 裕 水島 ４−ビフエニリル酢酸系化合物含有脂肪乳剤
US4760096A (en) * 1985-09-27 1988-07-26 Schering Corporation Moisturizing skin preparation
DE3623376A1 (de) * 1986-07-11 1988-01-21 Behringwerke Ag Pharmazeutische formulierung und verfahren zu deren herstellung
GB8919172D0 (en) * 1989-08-23 1989-10-04 Univ Nottingham Useful composition
JP2785981B2 (ja) * 1989-11-20 1998-08-13 株式会社資生堂 乳化組成物
US5089268A (en) * 1990-05-02 1992-02-18 Katz David P Egg phosphatide lipid emulsions altered for a specific therapeutic fatty acid composition

Also Published As

Publication number Publication date
AU701512B2 (en) 1999-01-28
HUT74638A (en) 1997-01-28
ZA947351B (en) 1995-04-10
JPH09504279A (ja) 1997-04-28
EP0722316B1 (en) 2000-01-26
SK39396A3 (en) 1997-02-05
SE9303281D0 (sv) 1993-10-07
DE69422818T2 (de) 2000-07-27
SG47896A1 (en) 1998-04-17
DK0722316T3 (da) 2000-06-13
NZ274583A (en) 1998-01-26
US5660837A (en) 1997-08-26
NO961363L (no) 1996-04-02
TNSN94099A1 (fr) 1995-04-25
DE69422818D1 (de) 2000-03-02
WO1995009609A1 (en) 1995-04-13
IL111131A (en) 1999-09-22
GR3033255T3 (en) 2000-09-29
CZ94396A3 (en) 1996-06-12
ES2145158T3 (es) 2000-07-01
FI961525A (fi) 1996-04-04
CA2172143A1 (en) 1995-04-13
CN1134663A (zh) 1996-10-30
EG20540A (en) 1999-07-31
ATE189119T1 (de) 2000-02-15
AU7866794A (en) 1995-05-01
US5843465A (en) 1998-12-01
PL313767A1 (en) 1996-07-22
HK1009257A1 (en) 1999-05-28
EP0722316A1 (en) 1996-07-24
HU9600900D0 (en) 1996-05-28
PT722316E (pt) 2000-06-30
BR9407748A (pt) 1997-11-11
MA23344A1 (fr) 1995-07-01
IS4209A (is) 1995-04-08
IL111131A0 (en) 1994-12-29
FI961525A0 (fi) 1996-04-04
NO961363D0 (no) 1996-04-02

Similar Documents

Publication Publication Date Title
EE03235B1 (et) Emulsioonvorm, selle valmistamise protsess ja kasutamine
SE9503143D0 (sv) New preparation
ATE213940T1 (de) Parenteral anzuwendende arzneizubereitung enthaltend amiodaron
ES2107832T3 (es) Una composicion farmaceutica para la administracion intranasal de hidroxocobalamina.
KR970706815A (ko) 온단세트론을 포함하는 경구 조성물(Oral Compositions Containing Ondansetron)
SE9402880D0 (sv) New peptide derivatives
DK0840607T3 (da) Ny medicinsk anvendelse
ES2189886T3 (es) Composicion farmaceutica para aplicacion topica.
RU94032792A (ru) Применение 5нтiа - антагонистов для прекращения использования табака